Tech Company Financing Transactions
Epicore Biosystems Funding Round
Epicore Biosystems secured a $26 million Series B funding round on 2/10/2025. Investors included Steele Foundation for Hope and private investors.
Transaction Overview
Company Name
Announced On
2/10/2025
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series B
Investors
Steele Foundation for Hope (Lead Investor)
Proceeds Purpose
The company intends to use the funds to drive global adoption of its personalized hydration and cloud analytics platform and expand into new biomarker targets relevant to kidney health, women's health, malnutrition and environmental toxin exposures.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
810 Memorial Dr. 100
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Epicore Biosystems has developed 'skin-like' wearable microfluidic solutions that are capable of non-invasively measuring sweat biomarkers, skin health, and physiology, in-real time.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roozbeh Ghaffari
Chief Operating Officer
John Wright
Chief Scientific Officer
AJ Aranyosi
Chief Technical Officer
Stephen Lee
VP - Engineering
Weihua Li
VP - Product Management
Jeffrey Model
Browse more venture capital transactions:
Prev: 2/10/2025: Drosera Network venture capital transaction
Next: 2/10/2025: &AI venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs